HIGH TECH PHARM CO.,LTD. Q3 operating profit KRW 1.1 billion, down 71.8% from a year earlier
AI summary · Not investment advice
Hi-Tech Pharm sold KRW 18.7 billion worth in Q3 and earned KRW 1.1 billion from its main business, down 71.8% from a year earlier.
Operating profit · 3 months
KRW 1.1 billion
Key facts
- Revenue (3 months)
- KRW 18.7 billion
- Net income (3 months)
- KRW -774.0 million
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 17.9 billion
- Revenue (year to date)
- KRW 56.2 billion
- Operating profit (prior-year 3 months)
- KRW 3.9 billion
- Operating profit (year to date)
- KRW 6.3 billion
- Net income (prior-year 3 months)
- KRW 3.8 billion
- Net income (year to date)
- KRW 4.2 billion
Commentary
AI commentary · Not investment advice
What happened
Hitech Pharm filed its quarterly report for the 3rd quarter of 2026, on a standalone basis. Sales for the 3 months were KRW 18.68 billion, up 4.6% from KRW 17.87 billion a year earlier.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 1.10 billion. That is down 71.8% from KRW 3.91 billion a year earlier. Net income (the final profit after taxes and other costs) for the 3 months was a loss of KRW 0.77 billion. A year earlier it was a profit of KRW 3.79 billion, so it turned into a loss.
What changes for shareholders
For the year to date (Jan 1 to Sep 30), sales were KRW 56.19 billion. Operating profit was KRW 6.30 billion and net income was KRW 4.20 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
H